Part Part 4 - National Health (Pharmaceutical Benefits - Therapeutic Groups) Determination 2010 (No. PB 1 of 2010) - H2RA group | Zoe

CTHRepealedLegislation

National Health (Pharmaceutical Benefits - Therapeutic Groups) Determination 2010 (No. PB 1 of 2010)

Part 4H2RA group

Start here

Get a plain-English read of Part 4

Turn the raw legal text into a practical explanation grounded in National Health (Pharmaceutical Benefits - Therapeutic Groups) Determination 2010 (No. PB 1 of 2010).

Ask Zoe about this section View in full context

Part 4—H2RA group

Item	Listed drug
3	Nizatidine